 Connection
Larry Moreland to Pilot Projects
This is a "connection" page, showing publications Larry Moreland has written about Pilot Projects.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.084 |
|
|
|
-
Moreland LW, Alten R, Van den Bosch F, Appelboom T, Leon M, Emery P, Cohen S, Luggen M, Shergy W, Nuamah I, Becker JC. Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion. Arthritis Rheum. 2002 Jun; 46(6):1470-9.
Score: 0.031
-
Moreland LW, Sewell KL, Trentham DE, Bucy RP, Sullivan WF, Schrohenloher RE, Shmerling RH, Parker KC, Swartz WG, Woodworth TG, et al. Interleukin-2 diphtheria fusion protein (DAB486IL-2) in refractory rheumatoid arthritis. A double-blind, placebo-controlled trial with open-label extension. Arthritis Rheum. 1995 Sep; 38(9):1177-86.
Score: 0.020
-
Moreland LW, Reddy MS, Koopman WJ, Webber RL, Alarcón GS, Jeffcoat MK. Digital subtraction radiography for the assessment of bone changes in rheumatoid arthritis. J Rheumatol. 1992 Nov; 19(11):1697-703.
Score: 0.016
-
Alarcón GS, Moreland LW, Sillers MJ, Morgan E, Carroll WR. A 2-phase screening process for patients with Wegener's granulomatosis: a pilot study. J Rheumatol. 2003 Nov; 30(11):2420-1.
Score: 0.009
-
Weisman MH, Moreland LW, Furst DE, Weinblatt ME, Keystone EC, Paulus HE, Teoh LS, Velagapudi RB, Noertersheuser PA, Granneman GR, Fischkoff SA, Chartash EK. Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study. Clin Ther. 2003 Jun; 25(6):1700-21.
Score: 0.008
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|